JP Morgan Chase’s Celularity CELU Stock Holding History
Bought
Maintained
Sold
Other funds holding CELU
JP Morgan Chase's CELU Position: Q3 2026 in Review
JP Morgan Chase held its Celularity (CELU) position steady in Q3 2026 at 16 shares worth $22. The position accounts for ﹤0.01% of the portfolio, ranked #7971.
JP Morgan Chase first reported a position in CELU in Q3 2020 and has held it in 21 quarters since. The position peaked at $11.7M in Q1 2021. 27 funds tracked by Wall St. Rank hold CELU as of Q3 2026.
- JP Morgan Chase held 16 shares of Celularity worth $22 as of Q3 2026.
- JP Morgan Chase left its Celularity share count unchanged in Q3 2026.
- Celularity made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #7971 holding.
- JP Morgan Chase first reported a position in Celularity in Q3 2020 and has held it in 21 quarters since.
- JP Morgan Chase's Celularity position peaked at $11.7M in Q1 2021.
- 27 funds tracked by Wall St. Rank held Celularity as of Q3 2026.
Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.